Adaptimmune LLC
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- adaptimmune.com
- Founded
- 2008
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Acer Therapeutics Inc. | Boston, MA | 456110 Pharmacies and Drug Retailers |
| Soleno Therapeutics Inc. | Redwood City, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Mallinckrodt ARD LLC | Hazelwood, MO | 325412 Pharmaceutical Preparation Manufacturing |
| Ionis Pharmaceuticals, Inc. | Carlsbad, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Phathom Pharmaceuticals, Inc. | Florham Park, NJ | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Adaptimmune LLC is a foreign-owned, for-profit corporate entity registered in the System for Award Management (SAM) with a primary focus on pharmaceuticals and medical products. While specific details about the company's core business are not provided in the award documentation, the federal contract history suggests the company specializes in manufacturing pharmaceutical and hematological products. The company is headquartered in Philadelphia, Pennsylvania, with a business registration that is currently valid through August 6, 2025, and is classified as a manufacturer of goods.
Adaptimmune LLC holds multiple Federal Supply Schedule (FSS) contracts, primarily with the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. These contracts are structured under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and cover procurement of drugs, pharmaceuticals, and hematology-related products. The company has been awarded three distinct contract IDVs: a Blanket Purchase Agreement (BPA) with a $5,525,200 ceiling value for TECELRA products, expiring in June 2026; a Federal Supply Schedule contract with a $225,000 ceiling value expiring in March 2030; and another FSS contract with a $25,000 ceiling value expiring in August 2025. These multiple-award contracts allow federal agencies to order products from pre-negotiated schedules, providing a streamlined procurement process for essential medical supplies and pharmaceuticals, with a specific focus on supporting veteran healthcare needs.
Quick answers
Is Adaptimmune LLC registered in SAM.gov?
Adaptimmune LLC's SAM.gov registration expired on August 4, 2026.
What is Adaptimmune LLC's CAGE code?
Adaptimmune LLC's CAGE code is 9P3M2, and its Unique Entity ID (UEI) is VMSVCL9NTHJ9.
Which contract vehicles does Adaptimmune LLC hold?
Adaptimmune LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
On GovTribe
See Adaptimmune LLC's full federal record
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors